Literature DB >> 11588127

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

P E Castle1, S L Hillier, L K Rabe, A Hildesheim, R Herrero, M C Bratti, M E Sherman, R D Burk, A C Rodriguez, M Alfaro, M L Hutchinson, J Morales, M Schiffman.   

Abstract

Previous reports of genital conditions, such as nonspecific genital infection/sore or vaginal discharge associated with cervical cancer (L. A. Brinton et al., J. Natl. Cancer Inst. (Bethesda), 79: 23-30, 1987; C. J. Jones et al., Cancer Res., 50: 3657-3662, 1990), suggest a possible link between either genital tract inflammation or changes in bacteria flora consistent with bacterial vaginosis (BV) and cervical cancer. To test whether changes in vaginal bacterial flora or the degree of cervical inflammation are associated with women having a human papillomavirus (HPV) infection or with women infected with oncogenic HPV having high-grade cervical lesions (high-grade squamous intraepithelial lesions or cancer), we conducted a case-control study of women <50 years old enrolled in the Costa Rican natural history study of HPV and cervical neoplasia. To test whether BV and inflammation were associated with HPV DNA positivity, Analysis 1 was restricted to women with no or mild (low-grade or equivocal) cytological abnormalities, and the degree of inflammation and Nugent score (a measure of BV) were compared between women infected (n = 220) and not infected (n = 130) with HPV. To test whether BV and inflammation were associated with high-grade lesions, Analysis 2 was restricted to women infected with oncogenic HPV, and the degree of inflammation and Nugent score were compared between women with (n = 95) and without (n = 158) high-grade cervical lesions. In Analysis 1, BV and cervical inflammation were not associated with HPV infection. In Analysis 2, BV was not associated with high-grade lesions. However, we found a marginally significant positive trend of increasing cervical inflammation associated with high-grade lesions in oncogenic HPV-infected women, (P(trend) = 0.05). Overt cervicitis was associated with a 1.9-fold increase in risk of high-grade lesions (95% confidence interval, 0.90-4.1). The results of this study suggest that cervical inflammation may be associated with high-grade lesions and may be a cofactor for high-grade cervical lesions in women infected with oncogenic HPV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588127

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  74 in total

1.  Viral and bacterial aetiologies of epithelial ovarian cancer.

Authors:  S Shanmughapriya; G Senthilkumar; K Vinodhini; B C Das; N Vasanthi; K Natarajaseenivasan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-09       Impact factor: 3.267

2.  Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women.

Authors:  Magdy A Al-Tahhan; Rasha L Etewa; Manal M El Behery
Journal:  Mol Cell Biochem       Date:  2011-03-23       Impact factor: 3.396

Review 3.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

4.  Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.

Authors:  Paula M Ferreira; Raquel Catarino; Deolinda Pereira; Ana Matos; Daniela Pinto; Ana Coelho; Carlos Lopes; Rui Medeiros
Journal:  Eur J Clin Pharmacol       Date:  2005-12-22       Impact factor: 2.953

5.  Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.

Authors:  Philip E Castle; Ana C Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

6.  Surgery: are we performing enough tonsillectomies?

Authors:  John Phillips; Andreas Hilger
Journal:  Nat Rev Clin Oncol       Date:  2009-08       Impact factor: 66.675

7.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

Review 8.  The microbiome and gynaecological cancer development, prevention and therapy.

Authors:  Paweł Łaniewski; Zehra Esra Ilhan; Melissa M Herbst-Kralovetz
Journal:  Nat Rev Urol       Date:  2020-02-18       Impact factor: 14.432

9.  Interleukin-1 beta-511 polymorphism and risk of cervical cancer.

Authors:  Sokbom Kang; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Sang Yoon Park; Soon Beom Kang; Hyo Pyo Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

10.  Leukocyte infiltration as a surrogate marker for diagnosis of invasion.

Authors:  Aijun Liu; Lixin Wei
Journal:  Int J Biol Sci       Date:  2010-04-28       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.